GEMVAX & KAEL
Gemvax & Kael Co., Ltd. manufactures chemical air filters used in semiconductor manufacturing process as well as equipments for general air purification system. The Company also produces Gas Srubber Resin, Coating Resin, and filters. Gemvax & Kael operates Environment System Field which includes media used for masks.
GEMVAX & KAEL
Industry:
Chemical Manufacturing
Founded:
1998-01-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.gemvax.com
Status:
Active
Contact:
+82 042-931-6287 I
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Google Apps For Business Java EE OpenSSL Apache 2.2 Unix OpenSSL 1.0.1
Similar Organizations
Daejung Chemicals & Metals Co
Daejung Chemicals & Metals manufactures reagent, fine and raw chemical materials used in industrial manufacturing & pharmaceutical products.
Official Site Inspections
http://www.gemvax.com Semrush global rank: 4.8 M Semrush visits lastest month: 1.9 K
- Host name: 121.78.246.132
- IP address: 121.78.246.132
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "GemVax & KAEL"
| GemVax & KAEL
GemVax Presents Poster on Topline Results of PSP Phase 2a Trial at International Conference . View More. MEDIA ASSET GemVax Corporate Poster. View More. INVESTMENT INFORMATION View More. CONTACT. TEL: +82) โฆSee details»
GemVax - Crunchbase Company Profile & Funding
GemVax Technology Co., Ltd. is a Korea-based company engaged in the manufacture of liquid crystal display (LCD) modules. The Company provides โฆSee details»
GemVax & KAEL - Crunchbase Company Profile & Funding
Gemvax & Kael Co., Ltd. manufactures chemical air filters used in semiconductor manufacturing process as well as equipments for general air purification system. The Company also โฆSee details»
GemVax & KAEL Co., Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GemVax & KAEL Co., Ltd. of Daejeon, Daejeon. Get the latest business insights from Dun & Bradstreet.See details»
GemVax & KAEL - LinkedIn
GemVax & KAEL | 141 followers on LinkedIn. GemVax will set you free. | Since 2008, GemVax & KAEL has operated as a cutting-edge research and development company developing proprietary peptide drug ...See details»
| GemVax & KAEL
CONTACT. TEL: +82) 31-708-5566, FAX: +82) 31-8016-2162, E-mail: [email protected] ADDRESS. 3F, 117, Unjung-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea ...See details»
GemVax to Present Topline Results at Neuro2024 International โฆ
Oct 22, 2024 We are pleased to announce that the 'Topline Results of the GemVax PSP Clinical Trial' will be presented at the Neuro2024 International Research Symposium in Toronto, โฆSee details»
GemVax & KAEL Co., Ltd.
Explore GemVax & KAEL Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 13 clinical trials, 3 news, and 17 literature, Disease Domain:Neoplasms, Nervous System โฆSee details»
GemVax - businessabc
Feb 25, 2025 GemVax was founded in 1995 with its headquarters located in South Korea. Since its inception, the company has conducted research in the fields of oncology, immunology, and โฆSee details»
GemVax - Funding, Financials, Valuation & Investors - Crunchbase
Nov 1, 2002 GemVax provides businesses with solutions and products that focus on preventing pollution of the environment. New. ... Pricing. Log In. Log In. Experience the new Crunchbase, โฆSee details»
Gemvax 2025 Company Profile: Valuation, Investors, Acquisition
Gemvax was founded in 2001. Where is Gemvax headquartered? Gemvax is headquartered in Porsgrunn, Norway. What industry is Gemvax in? Gemvaxโs primary industry is Drug โฆSee details»
| GemVax & KAEL
GemVax focuses on therapeutic strategies targeting glial cell-mediated neuroinflammation to treat neurodegenerative diseases. 1. Alzheimerโs disease (AD) Hallmarks. Amyloid ฮฒ plaques โฆSee details»
GemVax's highly promising Phase II Alzheimer's disease clinical โฆ
Mar 30, 2021 A GemVax official said: "The publication of GV1001 phase II Alzheimer's disease clinical trial results in the highly prestigious journal 'Alzheimer's Research & Therapy' is an โฆSee details»
GemVax & KAEL Co., Ltd. ESG Risk Rating - Sustainalytics
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, โฆSee details»
Tertomotide by GemVax & KAEL for Alzheimer's Disease: โฆ
Jan 19, 2025 The companyโs lead product candidate GV1001, an immunotherapeutic peptide is used for the treatment of advanced or metastatic pancreatic cancer. GemVax & KAEL is also โฆSee details»
Promising Phase II results underpin GemVax decision to apply for ...
SEOUL, South Korea, Oct. 6, 2020 /PRNewswire/ -- GemVax & KAEL (GemVax) a clinical stage company developing novel immunotherapies based on telomerase modification today โฆSee details»
GV1001 | ALZFORUM
Jan 24, 2023 In 2017, GemVax and Kael began a Phase 2 trial to assess safety and efficacy of GV1001 in people with moderate to severe Alzheimerโs disease at 13 sites in Korea. The โฆSee details»
Professor Ji-Young Lee, Principal Investigator of the PSP Clinical ...
Sep 27, 2024 CONTACT. TEL: +82) 31-708-5566, FAX: +82) 31-8016-2162, E-mail: [email protected] ADDRESS. 3F, 117, Unjung-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, โฆSee details»
GemVax | Biotech Careers
GemVax is a pioneering clinical-stage biopharmaceutical company based in Korea, dedicated to developing proprietary therapeutics for neurodegenerative diseases. Business Areas: โฆSee details»
| GemVax & KAEL
GemVax may permit the provision of investigational products to individuals with high unmet medical needs who are unable to participate in clinical trials and have no remaining treatment โฆSee details»